ghk-cu vs glow Peptide Therapy in Overland Park GLOW (GHK-Cu 50mg + BPC-157

These are investigational peptides studied in preclinical models for tissue repair and resilience

A peptide is a small chain of amino acids, the building blocks of proteins

Please make sure the liquid is clear before adding the next solvent

typical muscle loss with weight loss) Greater improvements in insulin sensitivity and lipid profiles Immune Optimization (Thymosin Alpha-1) Target Patient Profile: Chronic viral infections (EBV, Lyme, long COVID) Recurrent infections suggesting immune deficiency Cancer patients during or post-treatment Autoimmune conditions requiring immune modulation Recovery from severe illness or major surgery Treatment Protocol: Baseline: Complete immune panel including lymphocyte subsets (CD4, CD8, NK cells), inflammatory markers Dosing: 1.6 mg subcutaneously 2-3 times weekly for chronic support